5.19
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MYGN?
Forum
Prognose
Aktiensplit
Myriad Genetics Inc Aktie (MYGN) Neueste Nachrichten
Myriad (MYGN) up 4.1% since last earnings report: Can it continue? - MSN
Myriad Genetics (NASDAQ: MYGN) sets 2026 votes and outlines cancer-focused growth - Stock Titan
Myriad Genetics Expands MyChoice Test Access for Prostate Cancer Patients in Japan - National Today
Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan - Bitget
Japan clears Myriad test for prostate cancer patients using Lynparza - Stock Titan
GeneCentric to Present Data on Fragmentomics-Based ExpressCT™ Liquid Biopsy Technology at AACR 2026 - Yahoo Finance
Myriad Genetics jumps after Q4 beat; sees Q1 revenue rising 2%–4% Y/Y - MSN
Sectors Review: What is the next catalyst for Myriad Genetics IncPortfolio Return Report & Low Risk High Reward Ideas - baoquankhu1.vn
Should You Hold Myriad Genetics Stock in Your Portfolio Right Now? - MSN
MYGN Stock Price, Quote & Chart | MYRIAD GENETICS INC (NASDAQ:MYGN) - ChartMill
Lobbying Update: $30,000 of TIBER CREEK GROUP ON BEHALF OF MYRIAD GENETICS INC. lobbying was just disclosed - Quiver Quantitative
Myriad Genetics Underscores Commitment to Cancer Care Continuum with New Data Presentations at SGO Annual Meeting - ChartMill
Can Myriad Genetics Inc maintain its current growth rate2026 Opening Moves & Long Hold Capital Preservation Tips - baoquankhu1.vn
Trend Report: Can Myriad Genetics Inc maintain its current growth rate2026 Opening Moves & Long Hold Capital Preservation Tips - baoquankhu1.vn
Market Outlook: Whats next for Myriad Genetics Inc stockMarket Trend Report & AI Optimized Trade Strategies - baoquankhu1.vn
MYGN Technical Analysis | Trend, Signals & Chart Patterns | MYRIAD GENETICS INC (NASDAQ:MYGN) - ChartMill
Myriad Genetics, Inc. (MYGN) stock price, news, quote and history - Yahoo Finance UK
Myriad Genetics | SCHEDULE 13G/A: Others - Moomoo
BlackRock (NYSE: MYGN) holds 7.98M shares, 8.5% stake reported - Stock Titan
Myriad Genetics Q4 2025 Results: Revenue Beat, Raised GuidanceNews and Statistics - IndexBox
Myriad Genetics And 2 Other Penny Stocks To Watch Closely - Yahoo Finance
Myriad Genetics, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
Q4 Earnings Highlights: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks - Yahoo Finance
Myriad Genetics: Market Pricing in Failure as Catalysts Build for Re-Rating - Bitget
Myriad Genetics Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
Myriad Genetics Inc (MYD.HA) Stock Price, News, Quote & History - ca.finance.yahoo.com
3 Healthcare Stocks with Open Questions - Yahoo Finance
Myriad Genetics: SOTP Suggests The Company Is Undervalued - Seeking Alpha
Myriad Genetics, Inc. (MYD.F) Analyst insights, Price targets and Recommendations - Yahoo Finance Singapore
Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know - Yahoo Finance
Vanguard (MYGN) amendment shows 0 shares; subsidiaries disaggregate holdings - Stock Titan
Myriad Genetics, Inc. (NASDAQ:MYGN) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Myriad (MYGN) Up 4.1% Since Last Earnings Report: Can It Continue? - finance.yahoo.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Myriad Genetics launches Prequel Prenatal Screen using AMPLIFY technology for early chromosomal risk detection - Traders Union
Myriad Genetics (MYGN) CSO has shares withheld to cover RSU taxes - Stock Titan
Myriad Genetics (MYGN) COO has 2,055 shares withheld to cover taxes - Stock Titan
Myriad Genetics (MYGN) CFO uses 549 shares for RSU tax withholding - Stock Titan
Myriad Genetics, Inc.(NasdaqGS: MYGN) dropped from S&P 600 - marketscreener.com
Myriad Genetics, Inc.(NasdaqGS: MYGN) dropped from S&P Composite 1500 - marketscreener.com
Myriad Genetics, Inc.(NasdaqGS: MYGN) dropped from S&P 600 Health Care - marketscreener.com
Myriad Genetics, Inc.(NasdaqGS: MYGN) dropped from S&P 1000 - marketscreener.com
If You Invested $1,000 in Myriad Genetics (MYGN) - Stock Titan
Gene Patent Showdown For Myriad Comes to a Head - Yahoo
MYGN Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Why Myriad Genetics (MYGN) is a Top Growth Stock for the Long-Term - Yahoo Finance
Prequel Prenatal Screen enables providers to act on uncertain results, Myriad Genetics asserts - Traders Union
Why Myriad Genetics (MYGN) is a Top Momentum Stock for the Long-Term - Yahoo Finance
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):